Alexander Kuo MD FAASLD
Hepatology & Liver Transplantation
Medical Director, Liver Transplantation at Cedars-Sinai
Join to View Full Profile
8900 Beverly BlvdLos Angeles, CA 90048
Phone+1 310-423-6000
Dr. Kuo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alexander Kuo is a gastroenterologist specializing in hepatology and liver transplantation, based in West Hollywood, CA. He completed his medical education at the University of California San Francisco School of Medicine, followed by a residency at Massachusetts General Hospital and a fellowship in gastroenterology at UCSF. Dr. Kuo is the Medical Director of Liver Transplantation at Cedars-Sinai Medical Center and previously held positions at Virginia Mason Medical Center and UC San Diego Health. He is experienced in managing conditions such as primary sclerosing cholangitis, hepatitis B, hepatitis C, and hepatic cirrhosis. Dr. Kuo has contributed to multiple publications and clinical trials related to liver disease and transplantation. He was recognized as a Top Doctor by Seattle Magazine in 2018 and is a Fellow of the American Association for the Study of Liver Diseases.
Education & Training
University of California (San Francisco)Fellowship, Gastroenterology, 2004 - 2007
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2004- University of California San Francisco School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2004 - 2025
WA State Medical License 2017 - 2019
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Top Doctors Seattle Magazine, 2018
- Fellow, AASLD AASLD, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
- HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network Start of enrollment: 2011 Nov 01
- To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Recommendations to overcome barriers to transplant fellowship training: A report from the American Society of Transplantation Fellows Task Force.Jon Kobashigawa, Josh Levitsky, Neeraj Singh, Kiran Khush, Sean Pinney
American Journal of Transplantation. 2025-08-01 - 1 citationsExtracellular vesicle digital scoring assay for assessment of treatment responses in hepatocellular carcinoma patients.Chen Zhao, Yi-Te Lee, Andrew Melehy, Minhyung Kim, Jacqueline Ziqian Yang
Journal of Experimental & Clinical Cancer Research. 2025-05-01 - 1 citationsComparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation.Joseph C Ahn, Wee Han Ng, Yee Hui Yeo, Hyun-Seok Kim, Yun Wang
Hepatology. 2025-03-28
Professional Memberships
- American Association for the Study of Liver DiseasesMember
- European Association for the Study of the LiverMember
- American Society of TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
